Slides and Webcasts from all ESMO Preceptorships are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Preceptorship on Head & Neck Cancer 2022: Singapore
- Start date
- 23 Sep 2022
- End date
- 24 Sep 2022
- Location
- Singapore, Republic of Singapore
Learning Objectives
- To understand epidemiology, aetiology and molecular biology of nasopharyngeal cancer and squamous cell carcinoma of the head and neck (HNSCC)
- To understand multidisciplinary management and treatment of head and neck cancer
- To learn about advances in the treatment and novel targets in head and neck cancer
Accreditation
The programme of this event has been accredited with 11 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Boon-Cher Goh, Singapore
- Jean-Pascal Machiels, Belgium
